Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
With a fall in Net Sales of -16.36%, the company declared Very Negative results in Sep 25
With ROCE of 1.8, it has a Very Expensive valuation with a 1.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 563 Cr (Micro Cap)
195.00
39
0.28%
0.29
0.82%
1.61
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
Chemfab Alkalis Ltd’s shares declined sharply to a fresh 52-week low of Rs.395.7 on 20 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed its sector and broader market indices, reflecting persistent pressures on the company’s financial performance and valuation metrics.
Read full news article
Chemfab Alkalis Ltd Technical Momentum Shifts Amid Bearish Signals
Chemfab Alkalis Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest day gain of 1.17%, the stock’s broader technical outlook has deteriorated, prompting a downgrade to a Strong Sell rating by MarketsMOJO as of 7 July 2025.
Read full news article
Chemfab Alkalis Ltd Faces Continued Pressure Amid Mixed Technical Signals
Chemfab Alkalis Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a predominantly bearish outlook despite some mixed signals. The company’s stock price currently trades at ₹423.55, down 0.92% from the previous close, reflecting ongoing pressure amid a challenging commodity chemicals sector backdrop.
Read full news article Announcements 
Chemfab Alkalis Limited - Other General Purpose
04-Nov-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities
Chemfab Alkalis Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.0%)
Dr Rao Holdings Pte Ltd (47.07%)
V. M. Srinivasan (1.81%)
21.61%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -16.36% vs -0.84% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -178.82% vs 127.75% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -1.20% vs -5.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -89.29% vs -57.60% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






